Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody Drug Conjugate MYTX 011 in Subjects with Non Small Cell Lung Cancer
NCT Number:
NCT05652868
Phase:
I
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Lung
Study Objectives:
To evaluate the safety and tolerability of MYTX-011; To determine the recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) of MYTX-011
Study Documents
(MUSC NetID required for document access)